Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Medicare Advantage could become the default health-insurance program for all older adults. A recent proposal in Congress would automatically enroll older adults in a Medicare Advantage plan and then ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...

Humana (NYSE:HUM) plans to cut a third of prior authorizations and refiles a case against the government over its 2025 Medicare Star Ratings cut. Read more here.

Humana on Monday filed a new lawsuit over the U.S. government's reduction in the health insurer's star ratings for government ...

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

Humana Inc. lost its lawsuit seeking to reverse cuts to its Medicare bonus payments, a blow for the insurer that had hoped ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement System, known as Calpers.